Rotigotine transdermal system and evaluation of pain in patients with Parkinson's disease: A post hoc analysis of the RECOVER study

BMC Neurology

Volumn 14, Issue 1, 2014, Pages

  Kassubek, Jan ^a   Chaudhuri, Kallol R ^b,c   Zesiewicz, Theresa ^d   Surmann, Erwin ^e   Boroojerdi, Babak ^e   Moran, Kimberly ^e   Ghys, Liesbet ^e   Trenkwalder, Claudia ^f  

^a UNIVERSITY OF ULM   (Germany)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UCB PHARMA   (Belgium)

^f UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Dopamine receptor agonist; Pain; Parkinson's disease; Rotigotine

Indexed keywords

PLACEBO; ROTIGOTINE;

ARTICLE; DRUG DOSE TITRATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MUSCLE CRAMP; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PARKINSON DISEASE; POST HOC ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SLEEP DISORDER; UNIFIED PARKINSON DISEASE RATING SCALE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; DOPAMINE AGONISTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PARKINSON DISEASE; PROSPECTIVE STUDIES; TETRAHYDRONAPHTHALENES; THIOPHENES;

EID: 84897536964     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-14-42     Document Type: Article

References (30)

1. Broen MP, Braaksma MM, Patijn J, Weber WE. Prevalence of pain in Parkinson's disease:a systematic review using the modified QUADAS tool. Mov Disord 2012, 27:480-484.
2. Beiske AG, Loge JH, Rønningen A, Svensson E. Pain in Parkinson's disease:Prevalence and characteristics. Pain 2009, 141:173-177.
3. Broetz D, Eichner M, Gasser T, Weller M, Steinbach JP. Radicular and nonradicular back pain in Parkinson's disease:a controlled study. Mov Disord 2007, 22:853-856.
4. Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M. Pain as a nonmotor symptom of Parkinson disease:evidence from a case-control study. Arch Neurol 2008, 65:1191-1194.
5. Nègre-Pagès L, Regragui W, Bouhassira D, Grandjean H, Rascol O. Chronic pain in Parkinson's disease:the cross-sectional French DoPaMiP survey. Mov Disord 2008, 23:1361-1369.
6. Politis M, Wu K, Molloy S, G Bain P, Chaudhuri KR, Piccini P. Parkinson's disease symptoms:the patient's perspective. Mov Disord 2010, 25:1646-1651.
7. Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?. Mov Disord 2010, 25:2493-2500.
8. Quittenbaum BH, Grahn B. Quality of life and pain in Parkinson's disease:a controlled cross-sectional study. Parkinsonism Relat Disord 2004, 10:129-136.
9. Martinez-Martin P. The importance of non-motor disturbances to quality of life in Parkinson's disease. J Neurol Sci 2011, 310:12-16.
10. Roh JH, Kim BJ, Jang JH, Seo WK, Lee SH, Kim JH, Oh K, Park KW, Lee DH, Koh SB. The relationship of pain and health-related quality of life in Korean patients with Parkinson's disease. Acta Neurol Scand 2009, 119:397-403.
11. Ha AD, Jankovic J. Pain in Parkinson's disease. Mov Disord 2012, 27:485-491.
12. Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR. Postural deformities in Parkinson's disease. Lancet Neurol 2011, 10:538-549.
13. Wasner G, Deuschl G. Pains in Parkinson disease many syndromes under one umbrella. Nat Rev Neurol 2012, 8:284-294.
14. Ford B. Pain in Parkinson's disease. Mov Disord 2010, 25:S98-S103.
15. Stockwell KA, Scheller D, Rose S, Jackson MJ, Tayarani-Binazir K, Iravani MM, Smith LA, Olanow CW, Jenner P. Continuous administration of rotigotine to MPTP-treated common marmosets enhances anti-parkinsonian activity and reduces dyskinesia induction. Exp Neurol 2009, 219:533-542.
16. Elshoff JP, Braun M, Andreas JO, Middle M, Cawello W. Steady-state plasma concentration profile of transdermal rotigotine:an integrated analysis of three, open-label, randomized, phase I multiple dose studies. Clin Ther 2012, 34:966-978.
17. Trenkwalder C, Kies B, Rudzinska M, Fine J, Nikl J, Honczarenko K, Dioszeghy P, Hill D, Anderson T, Myllyla V, Kassubek J, Steiger M, Zucconi M, Tolosa E, Poewe W, Surmann E, Whitesides J, Boroojerdi B, Chaudhuri KR, Recover Study Group Rotigotine effects on early morning motor function and sleep in Parkinson's disease:a double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 2011, 26:90-99. Recover Study Group.
18. Plan EL, Elshoff JP, Stockis A, Sargentini-Maier ML, Karlsson MO. Likert pain score modeling:a Markov integer model and an autoregressive continuous model. Clin Pharmacol Ther 2012, 91:820-828.
19. Stocchi F, Barbato L, Nordera G, Berardelli A, Ruggieri S. Sleep disorders in Parkinson's disease. J Neurol 1998, 245:S15-S18.
20. Peto V, Jenkinson C, Fitzpatrick R. PDQ-39:a review of the development, validation and application of a Parkinson's disease quality of life questionnaire and its associated measures. J Neurol Sci 1998, 245:S10-S14.
21. Trenkwalder C, Kohnen R, Högl B, Metta V, Sixel-Döring F, Frauscher B, Hulsmann J, Martinez-Martin P, Chaudhuri KR. Parkinson's disease sleep scale-validation of the revised version PDSS-2. Mov Disord 2011, 26:644-652.
22. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, Bhattacharyya KB, Bloem BR, Carod-Artal FJ, Prakash R, Esselink RA, Falup-Pecurariu C, Gallardo M, Mir P, Naidu Y, Nicoletti A, Sethi K, Tsuboi Y, van Hilten JJ, Visser M, Zappia M, Chaudhuri KR. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009, 73:1584-1591.
23. Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients. Mov Disord 2004, 19:916-923.
24. Barone P, Bravi D, Bermejo-Pareja F, Marconi R, Kulisevsky J, Malagu S, Weiser R, Rost N, Pergolide Monotherapy Study Group Pergolide monotherapy in the treatment of early PD:a randomized, controlled study. Neurology 1999, 53:573-579. Pergolide Monotherapy Study Group.
25. Ghys L, Surmann E, Whitesides J, Boroojerdi B. Effect of rotigotine on sleep and quality of life in Parkinson's disease patients:post hoc analysis of RECOVER patients who were symptomatic at baseline. Expert Opin Pharmacother 2011, 12:1985-1998.
26. Storch A, Schneider CB, Wolz M, Sturwald Y, Nebe A, Odin P, Mahler A, Fuchs G, Jost WH, Chaudhuri KR, Koch R, Reichmann H, Ebersbach G. Nonmotor fluctuations in Parkinson disease:severity and correlation with motor complications. Neurology 2013, 80:800-809.
27. Lim SY, Evans AH. Pain and paresthesia in Parkinson's disease. Parkinson's Disease:Non-motor and Non-dopaminergic Features 2011, 315-332. Oxford, UK:Blackwell Publishing Ltd, Olanow CW, Stocchi F, Lang AE.
28. Brefel-Courbon C, Payoux P, Thalamas C, Ory F, Quelven I, Chollet F, Montastruc JL, Rascol O. Effect of levodopa on pain threshold in Parkinson's disease:a clinical and positron emission tomography study. Mov Disord 2005, 20:1557-1563.
29. Hagelberg N, Jääskeläinen SK, Martikainen IK, Mansikka H, Forssell H, Scheinin H, Hietala J, Pertovaara A. Striatal dopamine D2 receptors in modulation of pain in humans:a review. Eur J Pharmacol 2004, 500:187-192.
30. Chaudhuri KR, Martinez-Martin P, Antonini A, Brown RG, Friedman JH, Onofrj M, Surmann E, Ghys L, Trenkwalder C. Rotigotine and specific non-motor symptoms of Parkinson's disease:post hoc analysis of RECOVER. Parkinsonism Relat Disord 2013, 19:660-665.